4th Quarter - Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General heath care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act. 21st Century Cores Initiative

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (114th)

Medicare/Medicaid MMM

Medicare Part D issues. 340B Drug Pricing Program. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015. H.R. 1021 - Protecting the Integrity of Medicine Act. Issues pertaining to Importation.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1021 (114th), H.R. 2 (114th)

Budget/Appropriations BUD

S.Con.Res.11-An original concurrent resolution setting forth the congressional budget for the United States government for fiscal year 2016. Possible healthcare related pay-fors.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 11 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.